30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Brian Lian

Track

Insider profile

Currently holds positions in Seelos Therapeutics Inc and Viking Therapeutics Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 65% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Seelos Therapeutics Inc Jan. 24, 2019 -
President, Chief Executive Officer, Director Viking Therapeutics Inc June 3, 2015 -
Interim Chairman of the Board, President, Chief Executive Officer Viking Therapeutics Inc Sept. 1, 2012 - June 3, 2015
Brian Lian's trades of Viking Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-05 2026-01-05
PrS Proposed sale
36,728
244.62
US$2,187,838 		36,728 244.62 US$2,187,838
2026-01-05 2026-01-05
S Sale
44,779 +15.2%
74.82
US$2,764,208 		44,779 +15.2% 74.82 US$2,764,208
2026-01-05 2026-01-05
S Sale
22,851 -37.9%
164.18
US$4,758,626 		22,851 -37.9% 164.18 US$4,758,626
2026-01-05 2026-01-05
S Sale
53,279 -2.0%
33.38
US$1,778,267 		53,279 -2.0% 33.38 US$1,778,267
2026-01-05 2026-01-05
S Sale
132,454 -4.8%
32.29
US$4,277,032 		132,454 -4.8% 32.29 US$4,277,032
2025-10-28 2025-10-28
PrS Proposed sale
38,989
35.01
US$1,364,923 		38,989 35.01 US$1,364,923
2025-10-28 2025-10-28
S Sale
38,989 -1.6%
35.01
US$1,364,923 		38,989 -1.6% 35.01 US$1,364,923
2025-07-03 2025-07-03
PrS Proposed sale
26,889
27.80
US$747,633 		26,889 27.80 US$747,633
2025-07-03 2025-07-03
S Sale
26,889 -1.1%
27.80
US$747,633 		26,889 -1.1% 27.80 US$747,633
2025-01-06 2025-01-06
PrS Proposed sale
194,490
42.75
US$8,313,611 		194,490 42.75 US$8,313,611
2025-01-06 2025-01-06
S Sale
19,000 -0.8%
43.32
US$823,021 		19,000 -0.8% 43.32 US$823,021
2025-01-06 2025-01-06
S Sale
175,490 -6.9%
42.68
US$7,490,580 		175,490 -6.9% 42.68 US$7,490,580
2024-09-20 2024-09-20
PrS Proposed sale
216,130
18.41
US$3,978,372 		216,130 18.41 US$3,978,372
2024-09-20 2024-09-20
PlS Planned sale
200 -0.0%
71.99
US$14,397 		200 -0.0% 71.99 US$14,397
2024-09-20 2024-09-20
PlS Planned sale
119,874 -4.9%
71.15
US$8,529,047 		119,874 -4.9% 71.15 US$8,529,047
2024-09-20 2024-09-20
PlS Planned sale
96,056 -3.8%
70.43
US$6,765,109 		96,056 -3.8% 70.43 US$6,765,109
2024-08-22 2024-08-21
PlS Planned sale
1,000 -0.0%
69.90
US$69,900 		1,000 -0.0% 69.90 US$69,900
2024-08-21 2024-08-21
PrS Proposed sale
1,000
69.90
US$69,900 		1,000 69.90 US$69,900
2024-08-19 2024-08-19
PrS Proposed sale
112,870
65.79
US$7,425,717 		112,870 65.79 US$7,425,717
2024-08-19 2024-08-19
PlS Planned sale
11,296 -0.5%
67.12
US$758,194 		11,296 -0.5% 67.12 US$758,194
2024-08-19 2024-08-19
PlS Planned sale
31,442 -1.3%
66.37
US$2,086,821 		31,442 -1.3% 66.37 US$2,086,821
2024-08-19 2024-08-19
PlS Planned sale
70,132 -2.8%
65.33
US$4,581,492 		70,132 -2.8% 65.33 US$4,581,492
2024-07-31 2024-07-30
S Sale
30,417 -1.3%
58.78
US$1,787,911 		30,417 -1.3% 58.78 US$1,787,911
2024-07-31 2024-07-30
S Sale
19,501 -0.8%
57.81
US$1,127,353 		19,501 -0.8% 57.81 US$1,127,353
2024-07-31 2024-07-30
S Sale
65,941 -2.7%
56.95
US$3,755,340 		65,941 -2.7% 56.95 US$3,755,340
2024-07-30 2024-07-30
PrS Proposed sale
115,859
57.58
US$6,671,057 		115,859 57.58 US$6,671,057
2024-02-09 2024-02-09
PrS Proposed sale
45,000
29.20
US$1,314,000 		45,000 29.20 US$1,314,000
2024-02-09 2024-02-09
PlS Planned sale
45,000 -2.1%
29.90
US$1,345,500 		45,000 -2.1% 29.90 US$1,345,500
2024-02-08 2024-02-08
PrS Proposed sale
269,079
25.45
US$6,848,060 		269,079 25.45 US$6,848,060
2024-02-08 2024-02-08
PlS Planned sale
40,000 -1.8%
28.90
US$1,156,000 		40,000 -1.8% 28.90 US$1,156,000
2024-02-08 2024-02-08
PlS Planned sale
40,000 -1.8%
27.45
US$1,098,000 		40,000 -1.8% 27.45 US$1,098,000
2024-02-08 2024-02-08
PlS Planned sale
80,000 -3.4%
26.95
US$2,156,000 		80,000 -3.4% 26.95 US$2,156,000
2024-02-08 2024-02-08
PlS Planned sale
60,000 -2.5%
25.95
US$1,557,000 		60,000 -2.5% 25.95 US$1,557,000
2024-02-08 2024-02-08
PlS Planned sale
49,079 -2.1%
25.75
US$1,263,784 		49,079 -2.1% 25.75 US$1,263,784
2024-01-31 2024-01-31
PrS Proposed sale
85,000
24.71
US$2,100,750 		85,000 24.71 US$2,100,750
2024-01-31 2024-01-31
PlS Planned sale
45,000 -1.9%
24.95
US$1,122,750 		45,000 -1.9% 24.95 US$1,122,750
2024-01-31 2024-01-31
PlS Planned sale
40,000 -1.7%
24.45
US$978,000 		40,000 -1.7% 24.45 US$978,000
2024-01-30 2024-01-30
PrS Proposed sale
35,000
23.95
US$838,250 		35,000 23.95 US$838,250
2024-01-30 2024-01-30
PlS Planned sale
35,000 -1.5%
23.95
US$838,250 		35,000 -1.5% 23.95 US$838,250
2023-05-01 2023-05-01
PrS Proposed sale
45,000
22.45
US$1,010,250 		45,000 22.45 US$1,010,250
2023-05-01 2023-05-01
PlS Planned sale
45,000 -2.0%
22.45
US$1,010,250 		45,000 -2.0% 22.45 US$1,010,250
2023-04-21 2023-04-19
PlS Planned sale
35,000 -1.5%
21.45
US$750,750 		35,000 -1.5% 21.45 US$750,750
2023-04-19 2023-04-19
PrS Proposed sale
35,000
21.45
US$750,750 		35,000 21.45 US$750,750
2023-04-18 2023-04-17
PlS Planned sale
155,000 -6.4%
20.45
US$3,169,766 		155,000 -6.4% 20.45 US$3,169,766
2023-04-17 2023-04-17
PrS Proposed sale
155,000
20.45
US$3,169,750 		155,000 20.45 US$3,169,750